Department of Radiation Oncology

Medicine and Dentistry

1. Abdominal Cancer 8%
2. Adjuvant Radiotherapy 5%
3. Adjuvant Therapy 5%
4. Arm 6%
5. Breast Cancer 27%
6. Cervical Cancer 9%
7. Chemoradiation Therapy 8%
8. Chemoradiotherapy 31%
9. Chemotherapy 21%
10. Cisplatin 5%
11. Computer Assisted Tomography 6%
12. Conformal Radiotherapy 5%
13. Disease Free Survival 11%
14. Diseases 11%
15. Drug Megadose 7%
16. Esophageal Squamous Cell Carcinoma 7%
17. External Beam Radiotherapy 5%
18. Glioblastoma 6%
19. Hazard Ratio 9%
20. Hepatocellular Carcinoma 36%
21. Hypofractionated Radiotherapy 5%
22. Intensity Modulated Radiation Therapy 13%
23. Lung 5%
24. Lung Cancer 7%
25. Lymph Node 6%
26. Lymph Node Metastasis 8%
27. Magnetic Resonance Imaging 6%
28. Malignant Neoplasm 5%
29. Median Follow Up 13%
30. Multivariate Analysis 6%
31. Neoadjuvant Chemotherapy 5%
32. Neoplasm 22%
33. Non Small Cell Lung Cancer 21%
34. Overall Survival 37%
35. Pelvis 5%
36. Phase II Trials 5%
37. Positron Emission Tomography-Computed Tomography 7%
38. Prognostic Factor 11%
39. Progression Free Survival 14%
40. Prostate Cancer 7%
41. Proton Therapy 23%
42. Quadrantectomy 6%
43. Radiation Oncology 10%
44. Radiation Therapy 100%
45. Rectum Cancer 8%
46. Recurrence Free Survival 5%
47. Recurrent Disease 26%
48. Retrospective Study 11%
49. Stereotactic Body Radiation Therapy 5%
50. Survival Rate 14%
51. Transcatheter Arterial Chemoembolization 6%
52. Treatment Outcome 7%
53. Tumor 7%